Squalene Market Size & Growth Forecast 2027–2036, By Segments (Source, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to content
Market Size and Growth Outlook
Squalene Market size was more than USD 203.7 million in 2026 and is set to grow at a 10.36% CAGR between 2027 and 2036, exceeding USD 545.89 million by 2036. The industry revenue for 2027 is estimated at USD 221.46 million.
Get more details on this report
Request Free Sample ReportSqualene Market Intelligence Snapshot
Regional Market Dynamics
- Europe held 34.77% share in 2026, supported by strong cosmetics, personal care, and health applications, along with strict quality standards and mature regulated supply chains.
- Asia Pacific is projected to grow at 12.21% CAGR, driven by rising beauty, wellness, and nutraceutical demand, expanding processing capacity, and wider ingredient availability.
Segment Momentum
- Plants represented 78.19% of the market in 2026, supported by strong demand for dependable sourcing, formulation consistency, and ingredient transparency across large-scale commercial applications.
- Pharmaceuticals is the fastest-growing end-use segment as demand rises for specialized, high-value applications where squalene supports specific formulation and development requirements beyond consumer-focused products.
Market Expansion Drivers
- Expanding cosmetic demand for plant-based moisturizing and anti-aging skincare formulations.
- Increasing pharmaceutical use of squalene as vaccine adjuvant and drug delivery enhancer.
- Rising consumer shift toward bio-based and sustainable personal care ingredient sourcing.
Leading Market Participants
- Key companies in the squalene market include Croda International Plc (United Kingdom), BASF SE (Germany), Sophim S.A. (France), Kishimoto Special Liver Oil Co., Ltd. (Japan), Amyris, Inc. (USA), Vantage Specialty Chemicals (USA), ARISTA Industries, Inc. (USA), SeaDragon Marine Oils Ltd. (New Zealand), DSM-Firmenich AG (Netherlands), Evonik Industries AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 203.7 million
- 2027 Estimated Market Size: USD 221.46 million.
- Projected Market Size: USD 545.89 million by 2036
- Growth Forecast: 10.36% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Europe
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Plants (Source) | Personal Care & Cosmetics (End-use)
- Emerging Opportunity Segment: Animal (Source) | Pharmaceuticals (End-use)
Market Growth Drivers and Industry Trends
Expanding cosmetic demand for plant-based moisturizing and anti-aging skincare formulations
Expanding demand for plant-based skincare will drive the squalene market growth as cosmetic formulators increasingly seek emollient ingredients that support skin hydration, softness, and anti-aging product positioning. Squalene is valued for its compatibility with skin formulations and its ability to provide a smooth sensory profile, making it suitable for creams, serums, lotions, and other personal care products. The growing development of premium skincare products centered on moisturizing and age-management benefits is encouraging formulators to incorporate squalene into increasingly specialized cosmetic formulations.
Increasing pharmaceutical use of squalene as vaccine adjuvant and drug delivery enhancer
Increasing pharmaceutical use of squalene is strengthening the squalene market through its role as an important component in vaccine adjuvant systems and emerging drug delivery applications. Squalene-based adjuvants can support immune responses in selected vaccine formulations, while its chemical and formulation properties also make it relevant to specialized delivery systems. Continued development of pharmaceutical formulations and the need for effective excipients and adjuvant technologies are broadening the applications in which high-quality squalene can be utilized.
Rising consumer shift toward bio-based and sustainable personal care ingredient sourcing
The rising consumer shift toward bio-based and sustainable ingredient sourcing is creating favorable conditions for the squalene market as personal care manufacturers respond to greater scrutiny of raw material origins and environmental practices. Demand for responsibly sourced ingredients is encouraging formulators to evaluate alternatives to conventional petroleum-derived inputs while maintaining product performance and sensory characteristics. This trend is particularly relevant in skincare, where consumers increasingly associate plant-derived ingredients with cleaner formulation approaches and sustainability-oriented product attributes.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding cosmetic demand for plant-based moisturizing and anti-aging skincare formulations | 2.20% | Moderate | Europe, North America | High | Near Term |
| Increasing pharmaceutical use of squalene as vaccine adjuvant and drug delivery enhancer | 2.00% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Rising consumer shift toward bio-based and sustainable personal care ingredient sourcing | 1.60% | Moderate | Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Europe (Largest Region)
Europe held the largest share of the squalene market at 34.77% in 2026, supported by established demand for high-value cosmetic, personal care, and pharmaceutical ingredients. The region benefits from strong consumer interest in skin health, premium beauty formulations, and naturally derived ingredients, while manufacturers continue to emphasize product quality, purity, and sustainable sourcing. Growing adoption of squalene in moisturizers, serums, and other specialized formulations is reinforcing its position across mature personal care markets.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region for squalene, driven by expanding beauty and personal care consumption, rising disposable incomes, and increasing interest in skincare products with functional and premium ingredients. Growing awareness of skin wellness and the influence of advanced beauty trends are encouraging broader use of squalene in cosmetic formulations. Expansion of pharmaceutical and nutraceutical applications, alongside strengthening manufacturing capabilities, is further creating opportunities for regional demand.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Sustainable Ingredient ProcessingGermany emphasizes traceable and sustainably produced squalene for pharmaceutical and personal care applications. German manufacturers invest in alternative feedstocks and purification technologies that align with evolving formulation and regulatory expectations.
France 🇫🇷
Premium Personal Care FocusFrance supports the squalene market through luxury cosmetics and dermocosmetic product development. French manufacturers emphasize sustainably sourced ingredients and formulation performance that align with premium skincare positioning.
Italy 🇮🇹
Natural Cosmetic IngredientsItaly incorporates squalene into cosmetic, pharmaceutical, and wellness products that emphasize naturally derived ingredients. Italian producers prioritize ingredient quality and reliable sourcing to meet evolving formulation standards across personal care markets.
Japan 🇯🇵
Cosmetic Formulation DemandJapan incorporates squalene extensively into skincare and beauty formulations that prioritize product stability and skin compatibility. Japanese manufacturers continue refining high-purity ingredients suitable for premium cosmetic and healthcare applications.
South Korea 🇰🇷
Beauty Ingredient IntegrationSouth Korea relies on squalene as a valued ingredient within advanced skincare and cosmetic manufacturing. South Korean companies focus on plant-based sourcing options and formulation compatibility to strengthen premium personal care portfolios.
United States 🇺🇸
High-Purity ApplicationsThe U.S. squalene market is shaped by demand from cosmetics, pharmaceuticals, and dietary supplements requiring consistent ingredient quality. Companies in the U.S. increasingly favor sustainable sourcing and refined production methods to support premium formulations.
Squalene Market Share (%), by Source, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportSource Segment Analysis: Plants (Largest Segment) vs Animal (Fastest-Growing Segment)
Plant-derived sources led the squalene market with a 78.19% share in 2026, reflecting the growing preference for renewable and sustainable alternatives to animal-derived ingredients. Plant-based squalene is widely valued for its compatibility with personal care and cosmetic formulations, while its sourcing profile aligns with increasing demand for vegan, ethically positioned, and environmentally conscious ingredients. Greater emphasis on sustainable raw materials and responsible sourcing is reinforcing the attractiveness of plant-derived squalene across consumer and industrial applications.
The animal source segment is growing at the fastest pace as manufacturers continue to explore diverse raw material options for squalene applications, particularly where established processing capabilities and specific performance requirements support its use. Demand from specialized applications and continued interest in reliable ingredient supply are contributing to opportunities for animal-derived squalene. At the same time, improvements in purification and processing technologies can support more consistent quality and broaden its suitability for selected end uses.
End-use Segment Analysis: Personal Care & Cosmetics (Largest Segment) vs Pharmaceuticals (Fastest-Growing Segment)
Personal care & cosmetics accounted for the largest share of the squalene market, representing 67.3% in 2026, due to the ingredient's established use as an emollient and moisturizing component in skincare and cosmetic formulations. Squalene helps enhance skin feel and formulation performance, making it suitable for creams, serums, lotions, and other personal care products. Rising consumer interest in premium skincare, functional beauty ingredients, and sustainable sourcing is further supporting demand for squalene in cosmetic applications.
Pharmaceuticals are experiencing the fastest growth as squalene gains importance in specialized healthcare formulations and pharmaceutical applications. Its functional properties and compatibility with advanced formulation approaches are encouraging greater interest from the healthcare sector. Continued development of sophisticated drug and therapeutic formulations, together with increasing attention to high-quality specialty ingredients, is supporting the expanding role of squalene in pharmaceutical applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Source | Animal, Plants, Synthetic | Plants | Animal |
| End-use | Pharmaceuticals, Personal Care & Cosmetics, Nutraceuticals, Food & Beverages, Others | Personal Care & Cosmetics | Pharmaceuticals |
Competitive Landscape and Market Positioning
Key companies in the squalene market:
1. Croda International Plc (United Kingdom)
2. BASF SE (Germany)
3. Sophim S.A. (France)
4. Kishimoto Special Liver Oil Co. Ltd. (Japan)
5. Amyris Inc. (USA)
6. Vantage Specialty Chemicals (USA)
7. ARISTA Industries Inc. (USA)
8. SeaDragon Marine Oils Ltd. (New Zealand)
9. DSM-Firmenich AG (Netherlands)
10. Evonik Industries AG (Germany)
The squalene market is witnessing increasing innovation around bio-based extraction methods and high-purity formulations aimed at supporting cosmetic, pharmaceutical, and nutraceutical applications. Market participants are emphasizing sustainable sourcing strategies and advanced refining technologies to improve product quality and supply consistency. Expansion into premium skincare and wellness segments is further strengthening competitive differentiation within the squalene market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Croda International Plc (United Kingdom) | |||||||
| BASF SE (Germany) | |||||||
| Sophim S.A. (France) | |||||||
| Kishimoto Special Liver Oil Co. Ltd. (Japan) | |||||||
| Amyris Inc. (USA) | |||||||
| Vantage Specialty Chemicals (USA) | |||||||
| ARISTA Industries Inc. (USA) | |||||||
| SeaDragon Marine Oils Ltd. (New Zealand) | |||||||
| DSM-Firmenich AG (Netherlands) | |||||||
| Evonik Industries AG (Germany). |
Industry Development / News
| Company Name | Date | Key Development |
|---|---|---|
| PhytoGaia | May-25 | PhytoGaia launched a new range of palm-derived bioactive ingredients targeted at sustainable beauty applications. By strengthening the supply of plant-based alternatives to animal-derived squalene, this development directly supports the ongoing industry transition toward sustainable sourcing and addresses the growing demand for ethically produced emollients in the cosmetics sector. |
| Evonik Industries AG | Oct-23 | Evonik launched GMP-certified, plant-based squalene derived from amaranth oil for commercial and clinical use. This development provides a high-purity, sustainable alternative to traditional sources, specifically addressing the requirements for adjuvants in parenteral dosage forms and expanding the company's footprint in the pharmaceutical-grade ingredient segment. |
| Amyris | May-23 | Amyris partnered with Croda International Plc. to supply pharmaceutical-grade squalene for use as an immune-boosting adjuvant. The collaboration integrates Amyris's production capabilities with Croda's distribution network, significantly enhancing the commercial availability of sustainable squalene in the pharmaceutical and vaccine manufacturing supply chain. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Squalene Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Distribution Channel | Direct Sales, Distributors & Wholesalers, Online Channels |
| Buyer Type | Pharmaceutical & Nutraceutical Manufacturers, Cosmetics & Personal Care Manufacturers, Food & Beverage Manufacturers, Specialty Chemical Buyers |
| Product Form | Liquid Squalene, Encapsulated Squalene, Squalene-Based Formulations |
Squalene Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Bio-Based Squalene Transition Assessment |
|
| Vaccine Adjuvant Demand Outlook |
|
| Feedstock Sourcing & Traceability Assessment |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How much revenue does the squalene market generate?
How is the squalene industry size expected to evolve during the forecast period?
How is the shift toward plant-based cosmetic formulation influencing purchasing priorities in the squalene market?
Why is pharmaceutical demand creating a more specialized sourcing structure in the squalene market?
Why do plant-based sources dominate the squalene market?
What is driving growth in the pharmaceutical segment of the squalene market?
Which region leads the squalene market and why?
What is driving Asia Pacific growth in the squalene market?
What are the prominent companies operating in the squalene landscape?
Our Clients
"The report helped us understand emerging consumer trends in our product category. It clarified where to focus innovation for the next product launch."
LyondellBasell
"The regional forecast section was incredibly useful. We were able to identify two new potential partners in Europe thanks to the vendor mapping you included."
SABIC
"We appreciated how actionable the recommendations were. It guided us to improve supply chain resilience."
Olin Corporation
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook